Connect with Us at the Upcoming Events

With in-person events back again, Creative Biolabs is excited to greet you at the upcoming international conferences. Meet our team at 2022 BIO International Convention in June (booth #1754) and at the 13th Annual World ADC San Diego in September (booth number to be updated) for expert consultation on your drug discovery. Shoot an email to arrange an in-person meeting!

Book a Meeting

Anti-Human Complement component 9 (C9) Monoclonal Antibody (clone X197) -0.5 mg (CAT#: CB-P354-AB) Datasheet

Product Type
Antibody
Description
Human C9 is a 61 kD soluble glycoprotein. It is the last component in the assembly of the membrane attack complex (MAC). When complement is activated on the target membrane, multiple copies of C9 bind to the C5b-8 complex and assemble into barrel-shaped pores, causing cell lysis. The conformation of C9 changes from spherical to tubular. The combination of C9 and C5b-8 plays a key role in the function of C9.
Disease
Autoimmunity, Infectious diseases
Size
100 µg
Species
Human
Host
Mouse
Clonality
Monoclonal
Isotype
Mouse IgG1
Clone Number
X197
Buffer
PBS, containing 1% bovine serum albumin and 0.02% sodium azide
Application
Flow cytometry, Frozen sections, Immuno assays, Paraffin sections, Western blot
Application Notes
For immunohistology, the flow cytometer and Western blot diluent that will be used depend on the detection system used. It is recommended that users test reagents and determine their own optimal dilution. The typical initial working dilution is 1:10.
Storage Instructions
Product should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year.
Target
Complement component 9 (C9)
Alternative Names
Complement component 9; Complement 9

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK